Inhibition of CD62L+ T-cell response in vitro via a novel sulfo-glycolipid, β-SQAG9 liposome that binds to CD62L molecule on the cell surface

Cellular Immunology

Volumn 232, Issue 1-2, 2004, Pages 105-115

  Yamamoto, Yoshiteru ^a   Sahara, Hiroeki ^a   Takenouchi, Mika ^a   Matsumoto, Yoshitaka ^a   Imai, Akihito ^a   Fujita, Tatsuya ^a   Tamura, Yasuaki ^a   Takahashi, Nobuaki ^a   Gasa, Shinsei ^a   Matsumoto, Kenjiro ^b   Ohta, Keisuke ^b   Sugawara, Fumio ^b   Sakaguchi, Kengo ^b   Jimbow, Kowichi ^a   Sato, Noriyuki ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

CD62L+ T lymphocyte; Immunosuppresive drug; L selectin; MLR; Sulfoglycolipid

Indexed keywords

DETERGENT; GLUCOSE DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; L SELECTIN; LIGAND; LIPOSOME; PADGEM PROTEIN; SULFOQUINOVOSYL BETA DIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANTIGEN PRESENTING CELL; ARTICLE; BLOOD; CELL POPULATION; CELL SUBPOPULATION; CELL SURFACE; CONTROLLED STUDY; DRUG SOLUBILITY; DRUG STABILITY; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; LIGAND BINDING; MIXED LYMPHOCYTE REACTION; MOLECULE; NORMAL HUMAN; PRIORITY JOURNAL; STRUCTURE ANALYSIS; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ANTIGENS, SURFACE; GLYCOLIPIDS; HL-60 CELLS; HUMANS; L-SELECTIN; LEUKOCYTES, MONONUCLEAR; LIPOSOMES; LYMPHOCYTE CULTURE TEST, MIXED; P-SELECTIN; PROTEIN BINDING; T-LYMPHOCYTES;

ECHINOIDEA;

EID: 21144439270     PISSN: 00088749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellimm.2005.02.002     Document Type: Article

References (45)

1. R.Y. Calne, D.J. White, S. Thiru, D.B. Evans, P. McMaster, D.C. Dunn, G.N. Craddock, B.D. Pentlow, and K. Rolles Cyclosporine A in patients receiving renal allografts from cadaver donors Lancet 2 8140-8145 1978 1323 1327
2. T.E. Starzl, S. Todo, J. Fung, A.J. Demetris, R. Venkataramman, and A. Jain FK 506 for liver, kidney, and pancreas transplantation Lancet 2 8670 1989 1000 1004
3. European FK506 Multicentre Liver Study Group, Randomised trial comparing tacrolimus (FK506) and cyclosporine in prevention of liver allograft rejection, Lancet 344 (8920) (1994) 423-428
4. J.F. Borel Pharmacology of cyclosporine (Sandimmune). IV. Pharmacological properties in vivo Pharmacol. Rev. 41 1994 259 371
5. T. Kino, H. Hatanaka, S. Miyata, N. Inamura, M. Nishiyama, T. Yajima, T. Goto, M. Okuhara, M. Kohsaka, H. Aoki, and T. Ochiai FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro J. Antibiot. 40 1987 1256 1265
6. J. Liu, J.D. Farmer Jr., W.S. Lane, J. Friedman, I. Weissman, and S.L. Schreiber Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes Cell 66 1991 807 815
7. D.A. Fruman, C.B. Klee, B.E. Bierer, and S.J. Burakoff Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporine A Proc. Natl. Acad. Sci. USA 89 1992 3686 3690
8. S.J. O'Keefe, J. Tamura, R.L. Kincaid, M.J. Tocci, and E.A. O'Neill FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin Nature 357 1992 692 694
9. P.S. Changelian, M.E. Flanagan, D.J. Ball, C.R. Kent, K.S. Magnuson, W.H. Martin, B.J. Rizzuti, P.S. Sawyer, B.D. Perry, W.H. Brissette, S.P. McCurdy, E.M. Kudlacz, M.J. Conklyn, E.A. Elliott, E.R. Koslov, M.B. Fisher, T.J. Strelevitz, K. Yoon, D.A. Whipple, J. Sun, M.J. Munchhof, J.L. Doty, J.M. Casavant, T.A. Blumenkopf, M. Hines, M.F. Brown, B.M. Lillie, C. Subramanyam, C. Shang-Poa, A.J. Milici, G.E. Beckius, J.D. Moyer, C. Su, T.G. Woodworth, A.S. Gaweco, C.R. Beals, B.H. Littman, D.A. Fisher, J.F. Smith, P. Zagouras, H.A. Magna, M.J. Saltarelli, K.S. Johnson, L.F. Nelms, S.G. Des Etages, L.S. Hayes, T.T. Kawabata, D. Finco-Kent, D.L. Baker, M. Larson, M.S. Si, R. Paniagua, J. Higgins, B. Holm, B. Reitz, Y.J. Zhou, R.E. Morris, J.J. O'Shea, and D.C. Borie Prevention of organ allograft rejection by a specific janus kinase 3 inhibitor Science 302 2003 875 878
10. A.M. Mattos, A.J. Olyaei, and W.M. Bennett Nephorotoxicity of immunosuppressive drugs: long-term consequence and challenges for the future Am. J. Kidney Dis. 35 2000 333 346
11. T.E. Starzl, J. Fung, M. Jordan, R. Shapiro, A. Tzakis, J. McCauley, J. Johnston, Y. Iwaki, A. Jain, M. Alessiani, and S. Toda Kidney transplantation under FK 506 JAMA 264 1990 63 67
12. J. McCauley The nephrotoxicity of FK506 as compared with cyclosporine Curr. Opin. Nephrol. Hypertens. 2 1993 662 669
13. K. Chiba, Y. Yanagawa, Y. Masubuchi, H. Kataoka, T. Kawaguchi, M. Ohtsuki, and Y. Hoshino FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rat. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing J. Immunol. 160 1998 5037 5044
14. K. Chiba, Y. Hoshino, C. Suzuki, Y. Masubuchi, Y. Yanagawa, M. Ohtsuki, S. Sasaki, and T. Fujita FTY720, novel immunosuppressant possessing unique mechanisms. I. Prolongation of skin allograft survival and synergistic effect in combination with cyclosporine in rat Transplant. Proc. 28 1996 1056 1059
15. Y. Hoshino, C. Suzuki, M. Ohtsuki, Y. Masubuchi, Y. Amano, and Y. Chiba FTY720, novel immunosuppressant possessing unique mechanisms. II. Long-term graft survival induction in rat heterotopic cardiac allograft and synergistic effect in combination with cyclosporine A Transplant. Proc. 28 1996 1060 1061
16. T. Kawaguchi, Y. Hoshino, F. Rahman, Y. Amano, H. Higashi, H. Kataoka, M. Ohtsuki, K. Teshima, K. Chiba, T. Kakefuda, and S. Suzuki FTY720, novel immunosuppressant possessing unique mechanisms. III. Synergistic prolongation of canine renal allograft survival in combination with cyclosporine A Transplant. Proc. 28 1996 1062 1063
17. Y. Mizushina, I. Watanabe, K. Ohta, M. Takemura, H. Sahara, N. Takahashi, S. Gasa, F. Sugawara, A. Matsukage, S. Yoshida, and K. Sakaguchi Studies on inhibitors of mammalian DNA polymerase alpha and beta: sulfolipids from a pteridophyte, Athyrium niponicum Biochem. Pharmacol. 55 1998 537 541
18. Y. Mizushina, X. Xu, A. Asahara, R. Takeuchi, M. Oshige, N. Shimazaki, M. Takemura, T. Yamaguchi, K. Kuroda, S. Linn, H. Yoshida, O. Koiwai, M. Saneyoshi, F. Sugawara, and K. Sakaguchi A sulphoquinovosyl diacylglycerol is a DNA polymerase epsilon inhibitor Biochem. J. 370 2003 299 305
19. K. Ohta, Y. Mizushina, N. Hirata, M. Takemura, F. Sugawara, A. Matsukage, S. Yoshida, and K. Sakaguchi Sulfoquinovosyl-diacylglycerol, KM043, a new potent inhibitor of eukaryotic DNA polymerases and HIV-reverse transcriptase type 1 from a marine red alga, Gigartina tenella Chem. Pharm. Bull. 46 1998 684 686
20. K. Ohta, Y. Mizushina, N. Hirata, M. Takemura, F. Sugawara, A. Matsukage, S. Yoshida, and K. Sakaguchi Action of a new mammalian DNA polymerase inhibitor, sulfoquinovosyldiacylglycerol Biol. Pharm. Bull. 22 1999 111 116
21. K. Ohta, S. Hanashima, Y. Mizushina, T. Yamazaki, M. Saneyoshi, F. Sugawara, and K. Sakaguchi Studies on a novel DNA polymerase inhibitor group, synthetic sulfoquinovosylacylglycerols: inhibitory action on cell proliferation Mutat. Res. 467 2000 139 152
22. C. Murakami, T. Kumagai, T. Hada, U. Kanekazu, S. Nakazawa, S. Kamisuki, N. Maeda, X. Xu, H. Yoshida, F. Sugawara, K. Sakaguchi, and Y. Mizushina Effects of glycolipids from spinach on mammalian DNA polymerases Biochem. Pharmacol. 65 2003 259 267
23. H. Sahara, M. Ishikawa, N. Takahashi, S. Ohtani, N. Sato, S. Gasa, T. Akino, and K. Kikuchi In vivo anti-tumour effect of 3′-sulphonoquinovosyl 1′-monoacylglyceride isolated from sea urchin (Strongylocentrotus intermedius) intestine Br. J. Cancer 75 1997 324 332
24. H. Sahara, S. Hanashima, T. Yamazaki, S. Takahashi, F. Sugawara, S. Ohtani, M. Ishikawa, Y. Mizushina, K. Ohta, K. Shimozawa, S. Gasa, K. Jimbow, K. Sakaguchi, N. Sato, and N. Takahashi Anti-tumor effect of chemically synthesized sulfolipids based on sea urchin's natural sulfonoquinovosylmonoacylglycerols Jpn. J. Cancer Res. 93 2002 85 92
25. J. Golik, J.K. Dickey, G. Todderud, D. Lee, J. Alford, S. Huang, S. Klohr, D. Eustice, A. Aruffo, and M.L. Agler Isolation and structure determination of sulfonoquinovosyl dipalmitoyl glyceride, a P-selectin receptor inhibitor from the alga Dictyochloris fragrans J. Nat. Prod. 60 1997 387 389
26. S. Loya, V. Reshef, E. Mizrachi, C. Silberstein, Y. Rachamim, S. Carmeli, and A. Hizi The inhibition of the reverse transcriptase of HIV-1 by the natural sulfoglycolipids from cyanobacteria: contribution of different moieties to their high potency J. Nat. Prod. 61 1998 891 895
27. K.R. Gustafson, J.H. Cardellina II, R.W. Fuller, O.S. Weislow, R.F. Kiser, K.M. Snader, G.M. Patterson, and M.R. Boyd AIDS-antiviral sulfolipids from cyanobacteria (blue-green algae) J. Natl. Cancer Inst. 81 1989 1254 1258
28. Y. Matsumoto, H. Sahara, T. Fujita, K. Shimozawa, M. Takenouchi, T. Torigoe, S. Hanashima, T. Yamazaki, S. Takahashi, F. Sugawara, Y. Mizushina, K. Ohta, N. Takahashi, S. Gasa, K. Jimbow, K. Sakaguchi, and N. Sato An immunosuppressive effect by synthetic sufonolipids deduced from sulfonoquinovosyl diacylglycerols of sea urchin Transplantation 74 2002 261 267
29. F. Sugawara, S. Hanashima, Y. Mizushina, T. Yamazaki, K. Ohta, M. Okada, T. Yamagata, K. Sakaguchi, S. Takahashi, H. Koshino, and H. Sahara An approach of chemical biology in the case of sulfolipids: from findings of natural products, structural determinations, chemical syntheses and pharmaceutical potentials to future therapeutic usage as a goal Bull. Marine Biomed. Inst. Sapporo Med. Univ. 4 1999 7 18
30. T. Mikami, K. Tsuchihashi, M. Kashiwagi, Y. Yachida, T. Daino, K. Hashi, T. Akino, and S. Gasa Characterization of a O-fatty-acylated sulfatide from equine brain Eur. J. Biochem. 255 1998 289 295
31. J.K. Welply, S.Z. Abbas, P. Scudder, J.K. Keene, K. Broschat, S. Casnocha, C. Gorka, C. Steininger, S.C. Howard, J.J. Schmuke, M. Graneto, J.M. Rotasaert, I.D. Manger, and G.S. Jacob Multivalent sialyl-LeX: potent inhibitors of E-selectin-mediated cell adhesion; reagent for staining activated endothelial cells Glycobiology 4 1994 259 265
32. A. Bangham, M. Standish, and J. Watkins Diffusion of univalent ions across the lamellae of swollen phospholipids J. Mol. Biol. 13 1965 238 252
33. Y. Suzuki, Y. Toda, T. Tamatani, T. Watanabe, T. Suzuki, T. Nakao, K. Murase, M. Kiso, A. Hasegawa, K. Tadanoaritomi, I. Ishizuka, and M. Miyasaka Sulfated glycolipids are ligands for lymphocyte homing receptor, L-selectin (LECAM-1), binding epitope in sulfated sugar chain Biochem. Biophys. Res. Commun. 190 1993 426 434
34. H. Ohmoto, K. Nakamura, T. Inoue, N. Kondo, Y. Inoue, K. Yoshino, H. Kondo, H. Ishida, M. Kiso, and A. Hasegawa Studies on selectin blocker. 1. Structure-activity relationship of sialyl Lewis X analogs J. Med. Chem. 39 1996 1339 1343
35. A. Varki Selectin ligands Proc. Natl. Acad. Sci. USA 91 1994 7390 7397
36. A. Varki Selectin ligands: will the real ones please stand up? J. Clin. Invest. 99 1997 158 162
37. 18), a novel immunosuppressive drug Biochem. Pharmacol. 68 2004 2379 2386
38. B. Cestaro, E. Pistolesi, N. Hershkowitz, and S. Gatt Preparation of asymmetric, cerebroside sulfate-containing phospholipids vesicles Biochim. Biophys. Acta 685 1982 13 20
39. E. Butcher, and L. Picker Lymphocyte homing and homeostasis Science 272 1996 60 66
40. + T cells that preferentially respond to recall antigen J. Immunol. 170 2003 28 32
41. F. Sallusto, D. Lenig, R. Forster, M. Lipp, and A. Lanzavecchia Two subsets of memory T lymphocytes with distinct homing potentials and effector functions Nature 401 1999 708 712
42. D. Camerini, S.P. James, I. Stamenkovic, and B. Seed Leu-8/TQ1 is the human equivalent of the Mel-14 lymph node homing receptor Nature 342 1989 78 82
43. D.A. Steeber, N.E. Green, S. Sato, and T.F. Tedder Lymphocyte migration in L-selectin-deficient mice. Altered subset migration and aging of the immune system J. Immunol. 157 1996 1096 1106
44. M.D. Catalina, M.C. Carroll, H. Arizpe, A. Takashima, P. Estess, and M.H. Siegelman The route of antigen entry determines the requirement for L-selectin during immune responses J. Exp. Med. 184 1996 2341 2351
45. C. Murakami, T. Yamazaki, S. Hanashima, S. Takahashi, M. Takemura, S. Yoshida, K. Ohta, H. Yoshida, F. Sugawara, K. Sakaguchi, and Y. Mizushina A novel DNA polymerase inhibitor and a potent apoptosis inducer: 2-mono-O-acyl-3-O-(alpha-d-sulfoquinovosyl) glyceride with stearic acid Biochim. Biophys. Acta 1645 2003 72 80